Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase Ib results for BioChaperone Lispro in type 1 diabetes

June 30, 2015

Volanesorsen named U.S. orphan drug for familial chylomicronemia syndrome

June 30, 2015

CHMP adopts positive opinions for Strensiq and Kanuma

June 29, 2015

Trial finds RVX-208 may benefit individuals with prediabetes

June 29, 2015

Scripps Research Institute receives NIH grant for novel diabetes treatments

June 29, 2015

Perle studies combination of oral cyclosporine and lansoprazole for type 1 diabetes

June 29, 2015

Recent Merck & Co. patent describes FFAR1 agonists

June 26, 2015

MicroBiome Therapeutics discloses clinical data on the antidiabetic drug NM-505

June 26, 2015

Sanofi presents soluble epoxide hydrolase inhibitors

June 25, 2015

Boehringer Ingelheim patent describes kinase inhibitors

June 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...